Business Context and Reporting Period
Company: Glucotrack, Inc. (GCTK)
Filing Type: Form 8-K (Current Report)
Date of Report: January 21, 2025
Reporting Period: Event date January 21, 2025
The filing discloses a regulatory milestone achieved by the Company regarding its quality management system.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing is limited to a regulatory disclosure event.
Material Changes
Regulatory Certification: On January 21, 2025, Glucotrack, Inc. announced it received ISO 13485:2016 certification from the British Standards Institute. This certification relates to the Company's quality management system for medical devices.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release (Exhibit 99.1) detailing the ISO certification but does not provide forward-looking financial guidance or specific operational outlooks beyond the certification achievement.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text. The information is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the scope of the ISO 13485:2016 certification and its applicability to specific product lines.
- Review the full text of the Press Release (Exhibit 99.1) for details on the certification process and future regulatory steps.
- Check subsequent filings (10-Q or 10-K) for financial impact or operational updates related to this certification.